Suppression of LPS-Induced Hepato- and Cardiotoxic Effects by Pulicaria petiolaris via NF-κB Dependent Mechanism.


Journal

Cardiovascular toxicology
ISSN: 1559-0259
Titre abrégé: Cardiovasc Toxicol
Pays: United States
ID NLM: 101135818

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 6 7 2019
medline: 30 9 2020
entrez: 6 7 2019
Statut: ppublish

Résumé

Recently, there is an increasing interest in searching for harmless natural products isolated from plant materials that can be used as beneficial dietary supplements and/or therapeutic drug candidates. The present study aimed to test the potential protective role of Pulicaria petiolaris (PP, Asteraceae) against hepatic and cardiotoxic effects associated with lipopolysaccharide (LPS) injection. PP was given orally for 5 days at two different doses before LPS injection. Results have shown that LPS induced remarkable hepatic and cardiac injurious effects in mice. Hepatic damage was evident through increased serum transaminases, lactate dehydrogenase (LDH), alkaline phosphatase (ALP), and activity. Estimation of high levels of serum creatine kinase-MB (CK-MB) and cardiac troponin I indicated cardiac damage. Histopathological examination of liver and heart confirmed the biochemical results. Increase in oxidative stress along with a depressed antioxidant status of liver and heart were observed in LPS-intoxicated animals. Furthermore, LPS induced activation of nuclear factor-κB (NF-κB) and subsequent elevation of inflammatory cytokines (TNF-α, IL-6). On the other hand, PP treatment successfully safeguards both organs against LPS-induced injury as indicated by the improvement of the biochemical and histopathological parameters. These results suggest that PP ameliorates LPS-induced hepatic and cardiac oxidative injurious effects via antioxidant and anti-inflammatory effects.

Identifiants

pubmed: 31273688
doi: 10.1007/s12012-019-09539-4
pii: 10.1007/s12012-019-09539-4
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antioxidants 0
Interleukin-6 0
Lipopolysaccharides 0
NF-kappa B 0
Plant Extracts 0
Tnf protein, mouse 0
Tumor Necrosis Factor-alpha 0
interleukin-6, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-129

Auteurs

Nishat Ahmed (N)

Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al Madinah Al Munawwarah, 30078, Saudi Arabia.

Dina Saad El-Agamy (DS)

Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al Madinah Al Munawwarah, 30078, Saudi Arabia.
Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.

Gamal Abdallah Mohammed (GA)

Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Department of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, 71524, Egypt.

Hany Abo-Haded (H)

Cardiology Unit, College of Medicine, Taibah University, Al Madinah Al Munawwarah, 30078, Saudi Arabia.

Mohamed Elkablawy (M)

Department of Pathology, College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, 30001, Saudi Arabia.
Department of Pathology, Faculty of Medicine, Menoufia University, Menoufia, 32511, Egypt.

Sabrin Ragab Mohamed Ibrahim (SRM)

Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Al Madinah Al Munawwarah, 30078, Saudi Arabia. sribrahim@taibahu.edu.sa.
Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt. sribrahim@taibahu.edu.sa.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH